William Blair Investment Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,145,498
Closed -$2.81M 453
2025
Q4
$2.81M Sell
1,145,498
-2,488,883
-68% -$10.8M 0.01% 350
2025
Q3
$24.4M Buy
3,634,381
+534,486
+17% +$3.49M 0.06% 265
2025
Q2
$18.2M Buy
3,099,895
+39,283
+1% +$256K 0.05% 292
2025
Q1
$25.7M Buy
3,060,612
+121,764
+4% +$1.09M 0.07% 252
2024
Q4
$21.9M Buy
2,938,848
+546,787
+23% +$3.66M 0.05% 301
2024
Q3
$13.9M Sell
2,392,061
-1,289,657
-35% -$8.28M 0.03% 319
2024
Q2
$24.5M Buy
3,681,718
+1,352,207
+58% +$10.9M 0.06% 272
2024
Q1
$30.4M Sell
2,329,511
-538,523
-19% -$7.18M 0.08% 241
2023
Q4
$36.6M Buy
2,868,034
+1,082,033
+61% +$10.9M 0.11% 188
2023
Q3
$23.4M Buy
1,786,001
+811,777
+83% +$14.9M 0.08% 253
2023
Q2
$24.9M Buy
974,224
+11,297
+1% +$292K 0.08% 255
2023
Q1
$24.3M Buy
962,927
+234,160
+32% +$5.5M 0.08% 251
2022
Q4
$16.8M Buy
728,767
+162,447
+29% +$3.74M 0.06% 277
2022
Q3
$12.5M Sell
566,320
-252,353
-31% -$4.88M 0.05% 292
2022
Q2
$11.7M Buy
+818,673
New +$13.8M 0.04% 300

Other funds holding TMCI

William Blair Investment Management's TMCI Position: Q1 2026 in Review

William Blair Investment Management sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 1,145,498 shares — an estimated $2.81M sold.

William Blair Investment Management first reported a position in TMCI in Q2 2022 and held it in 15 quarters. The position peaked at $36.6M in Q4 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • William Blair Investment Management reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • William Blair Investment Management sold 1,145,498 Treace Medical Concepts shares in Q1 2026, an estimated $2.81M.
  • William Blair Investment Management first reported a position in Treace Medical Concepts in Q2 2022 and held it in 15 quarters.
  • William Blair Investment Management's Treace Medical Concepts position peaked at $36.6M in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.